6.4 C
New York
Friday, December 2, 2022

Tag: RW-HPN-MF-01

A grant for the development of orphan products in the amount of $2.6 million has been awarded by the Food and Drug Administration of...

Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and commercialising products to treat rare diseases where there is an unmet medical...

- A word from our sponsors -

Follow us

HomeTagsRW-HPN-MF-01